These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 8790986)

  • 1. An inverted U-shaped curve for heptylphysostigmine on radial maze performance in rats: comparison with other cholinesterase inhibitors.
    Braida D; Paladini E; Griffini P; Lamperti M; Maggi A; Sala M
    Eur J Pharmacol; 1996 Apr; 302(1-3):13-20. PubMed ID: 8790986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-lasting antiamnesic effect of a novel anticholinesterase inhibitor (MF268).
    Braida D; Paladini E; Griffini P; Lamperti M; Colibretti L; Sala M
    Pharmacol Biochem Behav; 1998 Apr; 59(4):897-901. PubMed ID: 9586846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of scopolamine-induced deficits in radial maze performance by (-)-huperzine A: comparison with E2020 and tacrine.
    Wang T; Tang XC
    Eur J Pharmacol; 1998 May; 349(2-3):137-42. PubMed ID: 9671090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Huperzine A, a novel promising acetylcholinesterase inhibitor.
    Cheng DH; Ren H; Tang XC
    Neuroreport; 1996 Dec; 8(1):97-101. PubMed ID: 9051760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excitatory and inhibitory effects of second-generation cholinesterase inhibitors on rat gastrointestinal transit.
    Braida D; Virag W; Ottonello F; Sala M
    Pharmacol Res; 2000 Jun; 41(6):671-7. PubMed ID: 10816338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of novel 7-MEOTA-donepezil like hybrids and N-alkylated tacrine analogues in the treatment of quinuclidinyl benzilate-induced behavioural deficits in rats performing the multiple T-maze test.
    Misik J; Korabecny J; Nepovimova E; Cabelova P; Kassa J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Dec; 159(4):547-53. PubMed ID: 25690521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of orally administered donepezil hydrochloride (E2020), a novel treatment for Alzheimer's disease, on cholinesterase activity in rats.
    Kosasa T; Kuriya Y; Matsui K; Yamanishi Y
    Eur J Pharmacol; 2000 Feb; 389(2-3):173-9. PubMed ID: 10688981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of novel tacrine-related cholinesterase inhibitors in the reversal of 3-quinuclidinyl benzilate-induced cognitive deficit in rats--Is there a potential for Alzheimer's disease treatment?
    Misik J; Korabecny J; Nepovimova E; Kracmarova A; Kassa J
    Neurosci Lett; 2016 Jan; 612():261-268. PubMed ID: 26708634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of nicotinic receptors in the amelioration of cholinesterase inhibitors in scopolamine-induced memory deficits.
    Masuoka T; Kamei C
    Psychopharmacology (Berl); 2009 Oct; 206(2):259-65. PubMed ID: 19639304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scopolamine disrupts place navigation in rats and humans: a translational validation of the Hidden Goal Task in the Morris water maze and a real maze for humans.
    Laczó J; Markova H; Lobellova V; Gazova I; Parizkova M; Cerman J; Nekovarova T; Vales K; Klovrzova S; Harrison J; Windisch M; Vlcek K; Svoboda J; Hort J; Stuchlik A
    Psychopharmacology (Berl); 2017 Feb; 234(4):535-547. PubMed ID: 27885411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities.
    Cheng DH; Tang XC
    Pharmacol Biochem Behav; 1998 Jun; 60(2):377-86. PubMed ID: 9632220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central and peripheral activity of cholinesterase inhibitors as revealed by yawning and fasciculation in rats.
    Ogura H; Kosasa T; Kuriya Y; Yamanishi Y
    Eur J Pharmacol; 2001 Mar; 415(2-3):157-64. PubMed ID: 11274994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The T-maze continuous alternation task for assessing the effects of putative cognition enhancers in the mouse.
    Spowart-Manning L; van der Staay FJ
    Behav Brain Res; 2004 May; 151(1-2):37-46. PubMed ID: 15084419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the potassium channel blockers, apamin and 4-aminopyridine, on scopolamine-induced deficits in the delayed matching to position task in rats: a comparison with the cholinesterase inhibitor E2020.
    Poorheidari G; Stanhope KJ; Pratt JA
    Psychopharmacology (Berl); 1998 Feb; 135(3):242-55. PubMed ID: 9498727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donepezil reverses a mnemonic deficit produced by scopolamine but not by perforant path lesion or transient cerebral ischaemia.
    Higgins GA; Enderlin M; Fimbel R; Haman M; Grottick AJ; Soriano M; Richards JG; Kemp JA; Gill R
    Eur J Neurosci; 2002 Jun; 15(11):1827-40. PubMed ID: 12081663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinesterase inhibitors, donepezil and rivastigmine, attenuate spatial memory and cognitive flexibility impairment induced by acute ethanol in the Barnes maze task in rats.
    Gawel K; Labuz K; Gibula-Bruzda E; Jenda M; Marszalek-Grabska M; Filarowska J; Silberring J; Kotlinska JH
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Oct; 389(10):1059-71. PubMed ID: 27376896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ameliorative effects of azaindolizinone derivative ZSET845 on scopolamine-induced deficits in passive avoidance and radial-arm maze learning in the rat.
    Yamaguchi Y; Higashi M; Matsuno T; Kawashima S
    Jpn J Pharmacol; 2001 Nov; 87(3):240-4. PubMed ID: 11885975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenserine: a physostigmine derivative that is a long-acting inhibitor of cholinesterase and demonstrates a wide dose range for attenuating a scopolamine-induced learning impairment of rats in a 14-unit T-maze.
    Iijima S; Greig NH; Garofalo P; Spangler EL; Heller B; Brossi A; Ingram DK
    Psychopharmacology (Berl); 1993; 112(4):415-20. PubMed ID: 7871051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donepezil, a centrally acting acetylcholinesterase inhibitor, alleviates learning deficits in hypocholinergic models in rats.
    Ogura H; Kosasa T; Kuriya Y; Yamanishi Y
    Methods Find Exp Clin Pharmacol; 2000 Mar; 22(2):89-95. PubMed ID: 10849891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonism of anticholinesterase (DFP) toxicity by donepezil plus scopolamine: a preliminary study.
    Janowsky DS; Davis JM; Overstreet DH
    Pharmacol Biochem Behav; 2004 Feb; 77(2):337-43. PubMed ID: 14751462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.